Related references
Note: Only part of the references are listed.Inflammatory eye reactions in patients treated with bisphosphonates and other osteoporosis medications: Cohort analysis using a national prescription database
Michael Pazianas et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Bisphosphonate Use Is Associated With Reduced Risk of Myocardial Infarction in Patients With Rheumatoid Arthritis
Frederick Wolfe et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Analysis of the association between bisphosphonate treatment survival in Danish hip fracture patients-a nationwide register-based open cohort study
L. Bondo et al.
OSTEOPOROSIS INTERNATIONAL (2013)
Hemorheological changes with strontium ranelate treatment do not seem to be related to its claimed prothrombotic effects
Zekeriya Ulger et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2012)
Incidence of Venous Thromboembolism in Users of Strontium Ranelate An Analysis of Data from a Prescription-Event Monitoring Study in England
Vicki Osborne et al.
DRUG SAFETY (2010)
Effect of Osteoporosis Treatment on Mortality: A Meta-Analysis
Mark J. Bolland et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Treatment of osteoporosis: recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity
P. Musette et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Validity of stroke diagnoses in a national register of patients
Lars-Henrik Krarup et al.
NEUROEPIDEMIOLOGY (2007)
The validity of the diagnosis of acute myocardial infarction in routine statistics: A comparison of mortality and hospital discharge data with the Danish MONICA registry
M Madsen et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2003)
Share Paper
